新股消息 | 佰泽医疗通过港交所聆讯 专注于提供肿瘤全周期医疗服务

智通财经
Yesterday

智通财经APP获悉,据港交所6月6日披露,佰泽医疗集团(佰泽医疗)通过港交所主板上市聆讯,招银国际为其独家保荐人。据招股书,佰泽医疗是“肿瘤全周期医疗服务”领域的服务供货商,筛查、诊断、治疗及康复是该公司在肿瘤全周期医疗服务体系中提供的核心服务。公司专注于开展肿瘤相关医疗服务,包括但不限于对患者开展肿瘤诊断、多种手段的肿瘤治疗、肿瘤康复及临终关怀等,以及对包括肿瘤患者家属在内的其他潜在健康人群开展...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10